[Bio-software] Structure-Based Design Conference - Next Month in Cambridge, Mass.

[Jim Prudhomme]

Dear Colleagues,

CHI's Tenth Annual Structure-Based Drug Design conference will be held on
June 23-25, 2010 at the Royal Sonesta
Hotel in Cambridge, Massachusetts. www.healthtech.com/sbd

Hear from thought-leaders including:

Structure-Based Design of AP24534, a pan-BCR-ABL Inhibitor Overriding the
T315I Gatekeeper Mutation
David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD
Pharmaceuticals, Inc.

Implementation of Protein Flexibility and Water Molecules in Docking and
Scoring Methods
Nicolas Moitessier, Ph.D., Professor, Chemistry, McGill University

The Impact of Recent X-Ray Structure Determinations on Structure-Based Drug
Design for GPCRs and other CNS Targets
Sid Topiol, Ph.D., Head of US Computational Chemistry and Structural
Investigations, Chemistry, Lundbeck Research, USA

Co-Presentation: Achieving Remarkable Potency and Selectivity Against HCV
Protease by Irreversible Covalent Inhibition Using Structure-Based Drug
Design
Deqiang Niu, Ph.D., Principal Scientist/Project Leader, Medicinal Chemistry,
Avila Therapeutics
Juswinder Singh, Ph.D., Co-Founder/Chief Scientific Officer, Avila
Therapeutics

Coupling the GPCR Structural Determination Process with Discovery and
Optimization of Small Molecule Ligands
Michael Hanson, Ph.D., Associate Director, Structural Biology, Receptos,
Inc.

Using Semi-Rational Design and Protein Folding to Engineer Highly Specific
Protein-Protein Interactions for Therapeutic Intervention
Jody Mason, Ph.D., Lecturer, Biological Sciences, University of Essex

For full details and to register, visit www.healthtech.com/sbd or call
781-972-5400.

If your organization would like details on sponsoring and/or exhibiting at
this conference, please contact
Katelin Fitzgerald at 781-972-5458 or email kfitzgerald from healthtech.com

Best regards,

James Prudhomme
Cambridge Healthtech Institute